Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
RNA (New York, N.Y.)|October 24, 2013
HAMR: high-throughput annotation of modified ribonucleotidesPaul Ryvkin, Yuk Yee Leung, Ian M Silverman, et al.
Life Science Alliance|July 28, 2021
Dynamic changes in RNA-protein interactions and RNA secondary structure in mammalian erythropoiesisMengge Shan, Xinjun Ji, Kevin Janssen, et al.
NPJ Precision Oncology|April 1, 2024
Post-therapy emergence of an NBN reversion mutation in a patient with pancreatic acinar cell carcinomaMeredith S Pelster, Ian M Silverman, Joseph D Schonhoft, et al.
Molecular and Cellular Biology|June 6, 2018
Poly(C)-Binding Protein Pcbp2 Enables Differentiation of Definitive Erythropoiesis by Directing Functional Splicing of the Runx1 TranscriptLouis R Ghanem, Andrew Kromer, Ian M Silverman, et al.
Cancer Discovery|November 21, 2020
Clinicogenomic Analysis of <i>FGFR2</i>-Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to PemigatinibIan M Silverman, Antoine Hollebecque, Luc Friboulet, et al.
Molecular and Cellular Biology|November 4, 2015
The Poly(C) Binding Protein Pcbp2 and Its Retrotransposed Derivative Pcbp1 Are Independently Essential to Mouse DevelopmentLouis R Ghanem, Andrew Kromer, Ian M Silverman, et al.
Genome Biology|September 5, 2019
Impact of poly(A)-tail G-content on Arabidopsis PAB binding and their role in enhancing translational efficiencyTaolan Zhao, Qing Huan, Jing Sun, et al.
Molecular Cell|January 6, 2015
Global analysis of the RNA-protein interaction and RNA secondary structure landscapes of the Arabidopsis nucleusSager J Gosai, Shawn W Foley, Dongxue Wang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 8, 2014
Tissue-specific RNA-Seq in human evoked inflammation identifies blood and adipose LincRNA signatures of cardiometabolic diseasesYichuan Liu, Jane F Ferguson, Chenyi Xue, et al.
NPJ Precision Oncology|July 7, 2025
Exceptional response to the ATR inhibitor, camonsertib, in a patient with ALT+ metastatic melanomaNatalie Y L Ngoi, Ian M Silverman, Adrienne Johnson, et al.
Pageof 4